Evidence map›Paper›PMID 29404443›Full record

ArticleHepatology communications2017

Prediction of histologic alcoholic hepatitis based on clinical presentation limits the need for liver biopsy.

Nitzan C Roth, Behnam Saberi, Jared Macklin, Gary Kanel, Samuel W French, Sugantha Govindarajan, Anthony S Buzzanco, Andrew A Stolz, John A Donovan, Neil Kaplowitz

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Diagnosis and Severity Assessment of Alcohol-Related Liver Disease].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2020
    Review
  5. The knowns and unknowns of treatment for alcoholic hepatitis.The lancet. Gastroenterology & hepatology · 2020
    Review
  6. Review
  7. Article
  8. Severe alcoholic hepatitis: current perspectives.Hepatic medicine : evidence and research · 2019
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nitzan C RothKeck School of Medicine Division of Gastrointestinal and Liver Diseases, University of Southern California Los Angeles CA.ORCID 0000-0003-2079-2917
Behnam SaberiDivision of Liver Diseases Icahn School of Medicine at the Mount Sinai Hospital New York NY.
Jared MacklinKeck School of Medicine Division of Gastrointestinal and Liver Diseases, University of Southern California Los Angeles CA.
Gary KanelDepartment of Pathology University of Southern California Los Angeles CA.
Samuel W FrenchDepartment of Pathology and Laboratory Medicine, Harbor-University of California Los Angeles Medical Center Torrance CA.
Sugantha GovindarajanDepartment of Pathology and Laboratory Medicine, Harbor-University of California Los Angeles Medical Center Torrance CA.
Anthony S BuzzancoDepartment of Pathology and Laboratory Medicine, Harbor-University of California Los Angeles Medical Center Torrance CA.ORCID 0000-0002-6698-4060
Andrew A StolzKeck School of Medicine Division of Gastrointestinal and Liver Diseases, University of Southern California Los Angeles CA.
John A DonovanKeck School of Medicine Division of Gastrointestinal and Liver Diseases, University of Southern California Los Angeles CA.
Neil KaplowitzKeck School of Medicine Division of Gastrointestinal and Liver Diseases, University of Southern California Los Angeles CA.
University of Southern California · USUniversity of California, Los Angeles · USMount Sinai Hospital · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
Southern California Alcoholic Hepatitis Consortium Administrative CoreU01AA021884 · NIAAA · SOUTHERN CALIFORNIA INST FOR RES/EDUC · PI MORGAN, TIMOTHY ROSS · 2013 to 2016
$118k
NIAAA NIH HHS P50 AA011999NIAAA NIH HHS U01 AA021884NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

The clinical presentation of alcoholic hepatitis (AH) can be mimicked by other alcoholic liver diseases. The aim of this study was to identify clinical features that predict AH on liver biopsy. Biopsies from patients hospitalized for presumed severe AH were used to identify a derivation cohort (101 patients) and validation cohort (71 patients). Using histologic scores for hepatocyte ballooning, Mallory-Denk bodies, and lobular inflammation, 95 patient biopsies (55%) were classified as definite AH, 55 (32%) as possible AH, and 22 (13%) as no AH. Survival was similar among the groups, but mortality was significantly increased for patients with fatty change ≤50% on initial liver biopsy. An analysis limited to uninfected patients with definite AH or no AH in the derivation cohort identified a greater leukocyte count at admission and radiographic evidence of liver surface nodularity as independent predictors of definite AH on biopsy (

Identifiers

PMID29404443
PMCPMC5721404
OpenAlexW2771612935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.